Home >> Industry News >> Luminex acquires MilliporeSigma’s flow cytometry portfolio

Luminex acquires MilliporeSigma’s flow cytometry portfolio

image_pdfCreate PDF

The buyout is expected to contribute $40–$50 million in revenue to Luminex in 2019.

CAP TODAY
X